力大圖書

力大醫學圖書網 www.leaderbook.com.tw 歡迎使用國民旅遊卡！！

加入會員 | 首頁 | 服務 | 行銷回應 | 代訂 | 購物車 | 預訂清單

代訂書籍

加購書籍專區

▼ Classes
圖書類別

運費(購買金額未滿NT$1000，請自行加上運費)

-■ ■ ■ ■ ■ ■

圖書介紹

(熱病)The Sanford Guide to Antimicrobial Therapy 2025 (Pocket Edition)

-藥劑科

- 編號： -------1944272291

- 作者：MD David N. Gilbert

- 原價-2200 - (熱賣價)1500 - 節省 ↓32%

加入購物車

推薦指數：

- 內容介紹

The Sanford Guide to Antimicrobial Therapy 2025 (Pocket Edition)
作者 MD David N. Gilbert (Author), MD Henry F. Chambers (Author), MD Michael S. Saag (Author), MD Andrew T. Pavia, MD; Helen W. Boucher (Author), MD Douglas Black, PharmD; David O. Freedman, MD; Kami Kim, MD; Brian S. Schwartz (Author)

出版者 ‏ : ‎ Antimicrobial Therapy, Inc.; 口袋版 2025
語言 ‏ : ‎ English
Paperback ‏ : ‎ 339 頁
ISBN-10 ‏ : ‎ 1944272291
ISBN-13 ‏ : ‎ 978-1944272296

Sanford Guide helps you make the best infectious diseases treatment decisions, fast. This Pocket Edition has an approximate font size of 5.5 points. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides convenient, concise, and reliable information. The book includes a FREE 1-month trial of Sanford Guide Antimicrobial All Access, which provides expanded content, interactive tables and tools, and constant updates. Coverage Clinical syndromes, Pathogens (Bacterial, Fungal, Mycobacterial, Parasitic, Viral), Anti-infective agents (Dosing, Pediatric adjustments, Renal adjustments, Adverse effects, Activity, Pharmacology, Interactions), and Preventative therapy. The 2024-2025 respiratory virus season remains dominated by the triple threat posed by COVID-19, RSV and influenza. Vaccination remains the cornerstone of prevention. Recommendations for treatment, prophylaxis and prevention are distilled in Table 14A of this edition. For comprehensive coverage, we direct you to Sanford Guide digital content (sold separately - please inquire), which is constantly updated. Major updates include: Table 1—Updated with many changes, as always. Table 5—Updated based on evolving recommendations and updated guidelines for treatment of highly resistant bacteria, especially gram-negatives. Table 8—Updated drug information for pregnancy risk and lactation. Table 9—Pharmacology, extensively updated. Table 10—Antibiotic dosing, extensively updated. Table 16—Pediatric dosing, extensively updated. Table 17—Renal impairment dosing, extensively updated.